ABSTRACT Gitelman syndrome (GS) is a renal tubular disorder of the thiazide-sensitive sodium chloride cotransporter, which is located in the distal tubule of the loop of Henle. We present a rare case of GS complicated by severe hyponatraemia and hypophosphataemia. A 17-year-old boy was admitted to our institution with fever and lethargy. The workup revealed typical features of GS, i.e. hypokalaemia, hypomagnesaemia and metabolic alkalosis. In this report, we discuss the differential diagnoses and rationale for accepting GS as the most likely diagnosis. This case was complicated by severe hyponatraemia (115 mmol/L) and hypophosphataemia (0.32 mmol/L). We concluded that the syndrome of inappropriate secretion of antidiuretic hormones could not be ruled out and that respiratory alkalosis was the most likely aetiology of hypophosphataemia. This case report also generates an interesting discussion on water and electrolyte metabolism.
INTRODUCTION
Gitelman syndrome (GS) is one of the most frequently inherited renal tubular disorders. (1) It is an autosomal recessive disorder of the sodium-chloride transport in the thiazide-sensitive sodium chloride cotransporter (NCCT), which is located in the distal tubule. In the majority of the patients, this mutation is found in the SLC12A3 gene on chromosome 16q13 that encodes the thiazide-sensitive NCCT. (2) GS is characterised by hypokalaemia, hypomagnesaemia, metabolic alkalosis and low urinary calcium excretion. (3) Patients usually present in late childhood or early adolescence. The most important condition to include in the differential diagnoses of GS is Bartter syndrome (BS), an autosomal recessive disorder characterised by a defect in the Na-K-2Cl/ ROMK/Cl cotransporter located in the thick ascending limb of the loop of Henle. (2) Hyponatraemia and hypophosphataemia are not recognised features of GS. (3) Here, we present a case of GS that was complicated by severe hyponatraemia and hypophosphataemia.
To the best of our knowledge, there has been no published report of this nature.
CASE REPORT
A 17-year-old boy presented with fever that persisted for one month, cough and chest congestion for ten days, and lethargy for one week. He had a high-grade fever of up to 38° C, intermittent in nature, and associated with rigors and chills. His fever was relieved by antipyretics and antibiotics prescribed by a family physician.
However, the patient continued to feel extremely weak and lethargic. He was admitted with the working diagnosis of chest infection. Table I summarises the results of the laboratory investigations conducted in the patient.
A case of Gitelman syndrome with severe hyponatraemia and hypophosphataemia 
DISCUS SION
The combination of hypokalaemia, hypomagnesaemia and metabolic alkalosis is a common presentation of patients on the medical floor. (2) GS and Bartter syndrome are always considered in the differential diagnoses of such cases. Our patient fulfilled all of the diagnostic criteria for GS. In addition, the case was complicated by severe hyponatraemia and hypophosphataemia.
In the following paragraphs, we will discuss how we reached the diagnosis of GS and the most likely explanations for the hyponatraemia and hypophosphataemia in our patient.
The first step in the workup of hypokalaemia is urine potassium (urine K) measurement. 
Hypokalaemia and metabolic alkalosis are also features of Bartter syndrome. The serum magnesium concentration distinguishes between the two syndromes, being low in GS and normal in Bartter syndrome. (6) However, the key difference between the two syndromes is the level of urinary calcium excretion -low in GS but high in Bartter syndrome.
The usually accepted cut-off value is 2.5 mmol (100 mg) of calcium per 24 hours of urine. In our patient, the 24-hour urine calcium measurement was 1.8 mmol (74 mg) per day, which is very low and strongly favours a diagnosis of GS.
In summary, the following features were present in our patient and support a diagnosis of GS: an age of 17 years, normal to low blood pressure, hypokalaemia, metabolic alkalosis, hypomagnesaemia, and hypocalciuria. The second significant problem 
Another point to consider is that hydrochlorothiazide (HCTZ)
is a recognised cause of hyponatraemia. As GS is physiologically similar to the use of HCTZ, one may argue that the mechanism of hyponatraemia is similar in both circumstances. The aetiology of thiazide-induced hyponatraemia is multifactorial.
It has been suggested that renal sodium wasting, hypovolumia and an intracellular K deficit play a role in development of hyponatraemia. (10) However, an interesting observation is the impairment of free water excretion by thiazide diuretics, leading to slight volume expansion as a primary event. This, in turn, triggers or aggravates hyponatraemia. A similar phenomenon may be responsible for hyponatraemia in patients with GS, but it is difficult to distinguish from SIADH. The second patient with a serum sodium concentration of 116 mmol/L presented with mixed features of volume depletion and SIADH. (10, 11) The third problem noted in our patient was severe hypophosphataemia. Again, the initial key test is the measurement of urinary phosphorus in any case of hypophosphataemia. Urinary phosphorus > 3.2 mmol (100 mg)/day indicates renal loss, while a level < 3.2 mmol (100 mg)/day indicates either nonrenal loss or a transcellular shift. (12) In our patient, urine phosphorus concentration was very low at 1.0 mmol/L (3.1 mg/dL) and 1.49 mmol/L (4.6 mg/dL) at two different measurements. The estimated 24-hour urinary phosphorus was very much less than 32 mmol (100 mg)/day.
This extremely low urine phosphorus concentration ruled out renal loss as a cause of the hypophosphataemia. In addition, there was no gastrointestinal loss. Thus, the most likely explanation for the hypophosphataemia in our patient was a shift of phosphorus from the extracellular compartment to the intracellular compartment. Respiratory alkalosis is an important and known cause of such a cellular shift, (13) and this was present in our patient.
Thus, we concluded that respiratory alkalosis was the most likely explanation of hypophosphataemia in our patient. In the literature, there are only two case reports of severe hypophosphatemia in patients with GS. In Akhtar et al's report of a patient with GS and hypophosphataemia, no clear-cut aetiology of hypophosphataemia was identified. (14) On the other hand, increased urinary phosphate excretion was the suggested mechanism of hypophosphataemia in Katopodis et al's report. (15) In conclusion, GS was the final diagnosis in our patient. It was associated with severe hyponatraemia and hypophosphataemia.
Hyponatraemia was most likely secondary to SIADH, and hypophosphataemia secondary to respiratory alkalosis. We feel that this case report would contribute to the literature by generating an interesting discussion of renal physiology in relation to water and electrolyte metabolism.
